课题基金 / 基金详情

CONTINUOUS REGENERATION OF PERITONEAL DIALYSATE BY A HYBRID ARTIFICIAL KIDNEY SYSTEM

CONTINUOUS REGENERATION OF PERITONEAL DIALYSATE BY A HYBRID ARTIFICIAL KIDNEY SYSTEM
通过混合人工肾系统连续再生腹膜透析液
批准号:
11650822
负责人:
MINESHIMA Michio
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002

项目摘要

项目成果

MINESHIMA Michio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, a regeneration system for the spent dialysate of the peritoneal cavity using newly developed artificial renal tubules would be developed to improve the solute removal efficiency of the conventional peritoneal dialysis (CPD). Artificial renal tubules, however, have not been developed because the cells of renal tubules depended on several operating conditions and have showed no stable incubation. On the other hand, Bi-directional Peritoneal Dialysis (BPD) has been developed to regenerate the spent dialysate as a new peritoneal dialysis system. In the BPD, a preset volume of the peritoneal dialysate reciprocates between the patient's peritoneal cavity and a outside dialysate reservoir by a reversible pump, giving the system a drain phase and an infusion phase alternatively. In the drain phase, a part of the dwelt dialysate is drained through the PD catheter at 100 ml/min (QDR) and enters the reservoir. In the infusion phase, the dialysate in the reservoir is returned to the peritoneal cavity at 300 ml/min (QIN). In both phases, the add-on dialyzer purifies the peritoneal dialysate continually. In this study, solute removal characteristics of BPD were examined in uremic canine model. The urea reduction rate in BPD and CPD were 20.0 ± 7.2%(n=16) and 3.5 ± 3.6%(n=7), respectively. Creatinine showed a similar tendency. The advantages of BPD therapy in comparison with conventional CAPD can be summarized as follows :a) High efficiency for solute removalb) No vascular access and no anticoagulantc) Capability for bicarbonate dialysate usaged) Low protein loss by reducing the exchangese) Capability for drug infusion through the extracorporeal circuit
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
峰島 三千男: "次世代PD療法を展望する"腎と透析 別冊 2001,ハイパフォーマンスメンブレン'01,21世紀の末期腎不全医療を展望する. 51別冊. 22-25 (2001)
Michio Mineshima:“下一代 PD 治疗的展望”2001 年肾脏和透析特刊,高性能膜 01,21 世纪终末期肾病治疗的展望 51 特刊(2001 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
峰島 三千男: "腹膜透析から未来へのアプローチ"透析療法ネクスト. 1. 69-78 (2001)
峰岛道夫:“从腹膜透析走向未来”透析治疗下一篇。 1. 69-78 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Michio Mineshima: "Solute Removal Characteristics of Continuous Recirculating Peritoneal Dialysis in Experimental and Clinical Studies"ASAIO Journal 2000 : 46(1) ; 95-98. 46・1. 95-98 (2000)
峰岛道夫:“实验和临床研究中连续再循环腹膜透析的溶质去除特性”ASAIO Journal 2000:46(1);46-98(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Michio Mineshima: "Solute Removal Charactccristics of Continuous Rccirculating Peritoneal Dialysisin Experimental and Clinical Studies"ASAIO Journal. (in press).
峰岛道夫:“实验和临床研究中连续循环腹膜透析的溶质去除特征”ASAIO 杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Development of reading materials and an instrucitonal model that can foster learners' critical thinking skills through peer opinion exchanges
    Development of home hemodialysis system with navigator
    • 批准号:
      19500397
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2007
    • 负责人:
      MINESHIMA Michio
    • 依托单位:
    DEVELOPMENT OF A BLLOD PURIFICATION SYSTEM IN HOME WITH FILTRATE REGENERATION BY USING MEMBRANE DISTILLATION TECHNIQUE
    • 批准号:
      15500326
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      MINESHIMA Michio
    • 依托单位:
    DEVELOPMENT OF PERITONEAL DIALYSIS SYSTEM WITH A WEARABLE ARTIFICIAL KIDNEY UNDER NO DIOALYSATE REPLACEMENT
    • 批准号:
      13558118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.82万
    • 财政年份:
      2001
    • 负责人:
      MINESHIMA Michio
    • 依托单位:
    海外基金